Cardiopulmonary bypass

Source: Wikipedia, the free encyclopedia.
Cardiopulmonary bypass
codes
22570829
]

Cardiopulmonary Bypass (CPB) is a machine that temporarily takes over the function of the heart and lungs during a cardiac surgery by maintaining the circulation of blood and oxygen throughout the body.[1]

CPB is used during many heart surgeries to improve the safety of the patient during a heart procedure. The machine mechanically circulates and oxygenates blood throughout the patient's body while bypassing the heart and lungs. Additionally, it maintains perfusion to other body organs and tissues of the patient while the surgeon works in a bloodless surgical field.

The CPB is often referred to as a heart-lung machine, "the pump," or CPB pumps. CPB is operated by perfusionists, and is a form of extracorporeal circulation.

Uses

Illustration of one typical way that a heart-lung machine may be connected to the veins and arteries near the heart. The three implements on the left represent (from top to bottom) the pump, the oxygenator, and the reservoir.

CPB is commonly used in operations or surgical procedures involving the heart. The technique allows the surgical team to oxygenate and circulate the patient's blood, thus allowing the surgeon to operate safely on the heart. In many operations, such as coronary artery bypass grafting (CABG), the heart is arrested, due to the degree of the difficulty of operating on a beating heart.

Operations requiring the opening of the chambers of the heart, for example mitral valve repair or replacement, requires the use of CPB. This is to avoid engulfing air systemically, and to provide a bloodless field to increase visibility for the surgeon. The machine pumps the blood and, using an oxygenator, allows red blood cells to pick up oxygen, as well as allowing carbon dioxide levels to decrease. This mimics the function of the heart and the lungs, respectively.

Hypothermia

CPB can be used for the induction of total body

brain damage can occur in three to four minutes – death may follow. Similarly, CPB can be used to rewarm individuals who have hypothermia
. This rewarming method of using CPB is successful if the core temperature of the patient is above 16 °C.

Cooled Blood

The blood is cooled during CPB and is returned to the body. The cooled blood slows the body's basal metabolic rate, decreasing its demand for oxygen. Cooled blood usually has a higher viscosity, but the various crystalloid or colloidal solutions that are used to prime the bypass tubing serve to dilute the blood. Maintaining appropriate blood pressure for organs is a challenge, but it is monitored carefully during the procedure. Hypothermia is also maintained (if necessary), and the body temperature is usually kept at 28 °C to 32 °C (82.4–89.6 °F).

Extracorporeal Membrane Oxygenation (ECMO)

pulmonary embolisms
, lung trauma from infections, and a range of other problems that impair cardiac or pulmonary function.

ECMO gives the heart and/or lungs time to repair and recover, but is only a temporary solution. Patients with terminal conditions, cancer, severe nervous system damage, uncontrolled sepsis, and other conditions may not be candidates for ECMO.

When is Cardiopulmonary Bypass Used?

Contraindications and special considerations

There are no absolute contraindications to cardiopulmonary bypass.[6] However, there are several factors that need to be considered by the care team when planning an operation.

heparin-induced thrombocytopenia and thrombosis (HITT) are potentially life-threatening conditions associated with the administration of heparin. In both of these conditions, antibodies against heparin are formed which causes platelet activation and the formation of blood clots. Because heparin is typically used in CPB, patients who are known to have the antibodies responsible for heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis require alternative forms of anticoagulation. Bivalirudin is the most studied heparin-alternative in people with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis requiring CPB.[7]

A small percentage of patients, such as those with an antithrombin III deficiency, may exhibit resistance to heparin. In these patients, patients may need additional heparin, fresh frozen plasma, or other blood products such as recombinant anti-thrombin III to achieve adequate anticoagulation.[8]

A persistent left superior vena cava (PLSVC) is thoracic system variation in which the left-sided vena cava fails to involute during normal development. It is the most common variation of the thoracic venous system, occurring in approximately 0.3% of the population.[9] The abnormality is often detected on pre-operative imaging studies, but may also be discovered intra-operatively. A persistent left superior vena cava may make it difficult to achieve proper venous drainage or deliver of retrograde cardioplegia. Management of a persistent left superior vena cava during CPB depends on factors such as the size and drainage site of the vena cava variation.[10]

Risks and complications

Potential complications of cardiopulmonary bypass
Complication Incidence
(events/1000)
Death or serious
injury (%)
Protamine reaction[10] 1.3 10.5
Thrombosis[10] 0.3–0.4 2.6–5.2
Aortic dissection[10] 0.4–0.8 14.3–33.1
Gas embolism
0.2–1.3 0.2–8.7
Massive systemic gas embolism[10] 0.03–0.07 50–52
Dislodging of cannula (causing massive bleeding)[10] 0.2–1.6 4.2–7.1
Acute respiratory distress syndrome[10]
Arrythmias[10]
Capillary leak syndrome[11]
Hemolysis[11]
Postperfusion syndrome ("pumphead")[11]

CPB is not benign and there are a number of associated problems. As a consequence, CPB is only used during the several hours a cardiac surgery may take. CPB is known to activate the coagulation cascade and stimulate inflammatory mediators, leading to hemolysis and coagulopathies. This problem worsens as complement proteins build on the membrane oxygenators.[12] For this reason, most oxygenators come with a manufacturer's recommendation that they are only used for a maximum of six hours, although they are sometimes used for up to ten hours, with care being taken to ensure they do not clot off and stop working. For longer periods than this, an ECMO (extracorporeal membrane oxygenation) is used, which can be in operation for up to 31 days – such as in a Taiwanese case, for 16 days, after which the patient received a heart transplant.[13]

The most common complication associated with CPB is a protamine reaction during anticoagulation reversal.[10] There are three types of protamine reactions, and each may cause life-threatening hypotension (type I), anaphylaxis (type II), or pulmonary hypertension (type III).[14][12] Patients with prior exposure to protamine, such as those who have had a previous vasectomy (protamine is contained in sperm) or diabetics (protamine is contained in neutral protamine hagedorn (NPH) insulin formulations), are at an increased risk of type II protamine reactions due to cross-sensitivity.[12] Because protamine is a fast-acting drug, it is typically given slowly to allow for monitoring of possible reactions.[11] The first step in management of a protamine reaction is to immediately stop the protamine infusion. Corticosteroids are used for all types of protamine reactions. Chlorphenamine is used for type II (anaphylactic) reactions. For type III reactions, heparin is redosed and the patient may need to go back on bypass.[12]

CPB may contribute to immediate cognitive decline. The heart-lung blood circulation system and the connection surgery itself release a variety of debris into the bloodstream, including bits of blood cells, tubing, and plaque. For example, when surgeons clamp and connect the aorta to tubing, resulting emboli may block blood flow and cause mini strokes. Other heart surgery factors related to mental damage may be events of hypoxia, high or low body temperature, abnormal blood pressure, irregular heart rhythms, and fever after surgery.[15]

Components

Cardiopulmonary bypass devices consist of two main functional units: the pump and the oxygenator. These units remove oxygen-depleted blood from a patient's body and replace it with oxygen-rich blood through a series of tubes, also known as hoses. Additionally, a heat exchanger is used to control body temperature by heating or cooling the blood in the circuit. Note: It is important that all components of the circuit are coated internally by heparin or another anticoagulant to prevent clotting within the circuit.[10]

Perfusionist operating a modern heart lung machine

Tubing

The components of the CPB circuit are interconnected by a series of tubes made of

PVC.[16]

Pumps

Centrifugal pump

Many CPB circuits now employ a centrifugal pump for the maintenance and control of blood flow during CPB. By altering the speed of revolution (RPM) of the pump head, blood flow is produced by centrifugal force. This type of pumping action is considered to be superior to the roller pump because it is thought to prevent over-pressurization, clamping, or kinking of lines, and makes less damage to blood products (hemolysis, etc.).[17]

Roller pump

The pump console usually comprises several rotating, motor-driven pumps that peristaltically "massage" the tubing. This action gently propels the blood through the tubing. This is commonly referred to as a roller pump, or peristaltic pump. The pumps are more affordable than their centrifugal counterparts but are susceptible to over-pressurization if the lines become clamped or kinked.[17] They are also more likely to cause a massive air embolism and require constant, close supervision by the perfusionist.[10]

Oxygenator

The oxygenator is designed to add oxygen to infused blood and remove some carbon dioxide from the venous blood.

Heat exchangers

Because hypothermia is frequently used in CPB (to reduce metabolic demands), heat exchangers are implemented to warm and cool blood within the circuit. Heating and cooling is accomplished by passing the line through a warm or ice water bath, and a separate heat exchanger is required for the cardioplegia line.[10]

Cannulae

Multiple cannulae are sewn into the patient's body in a variety of locations, depending on the type of surgery. A venous cannula removes oxygen depleted venous blood from a patient's body, and an arterial cannula infuses oxygen-rich blood into the arterial system. The main determinants of cannula size selection is determined by the patient's size and weight, anticipated flow rate, and the size of the vessel being cannulated.[10] A Cardioplegia cannula delivers a Cardioplegia solution to cause the heart to stop beating.

Some commonly used cannulation sites:

Venous Arterial Cardioplegia
Right atrium
Proximal aorta, distal to the cross-clamp Proximal aorta, proximal to the cross-clamp
Vena cavae
Femoral artery Coronary sinus (retrograde delivery)
Femoral vein Axillary artery Coronary ostia
Distal aorta Bypass grafts (during
CABG
)
Apex of the heart

Cardioplegia

Cardioplegia is a fluid solution used to protect the heart during CPB. It is delivered via a cannula to the opening of the coronary arteries (usually by way of the aortic root) and/or to the cardiac veins (by way of the coronary sinus).

myocytes.[18]

Technique

Pre-operative planning

CPB requires significant forethought before surgery. In particular, the cannulation, cooling, and cardio-protective strategies must be coordinated between the surgeon, anesthesiologist, perfusionist, and nursing staff.[17]

Cannulation Strategy

The cannulation strategy varies on several operation-specific and patient-specific details. Nonetheless, a surgeon will place a cannula in the right atrium, vena cava, or femoral vein to withdraw blood from the body. The cannula used to return oxygenated blood is usually inserted in the ascending aorta, but there is a possibility that it is inserted in the femoral artery, axillary artery, or brachiocephalic artery according to the demand of the surgery.[19][20] After the cannula is inserted, venous blood is drained from the body by the cannula into a reservoir. This blood is then filtered, cooled, or warmed, and oxygenated before it returns to the body through a mechanical pump.

Intra-Operative Technique

A CPB circuit must be primed with fluid and all air expunged from the arterial line/cannula before connection to the patient. The circuit is primed with a

crystalloid solution and sometimes blood products are also added. Prior to cannulation (typically after opening the pericardium when using central cannulation), heparin or another anticoagulant is administered until the activated clotting time is above 480 seconds.[11]

The arterial cannulation site is inspected for

pursestring sutures are placed in the distal ascending aorta. A stab incision with a scalpel is made within the pursestrings and the arterial cannula is passed through the incision. It is important the cannula is passed perpendicular to the aorta to avoid creating an aortic dissection.[11] The pursestrings sutures are cinched around the cannula using a tourniquet and secured to the cannula.[17] At this point, the perfusionist advances the arterial line of the CPB circuit and the surgeon connects the arterial line coming from the patient to the arterial line coming from the CPB machine. Care must be taken to ensure no air is in the circuit when the two are connected, or else the patient could develop an air embolism.[18][11] Other sites for arterial cannulation include the axillary artery, brachiocephalic artery, or femoral artery
.

Aside from the differences in location,

right atrial appendage, through the tricuspid valve, and into the inferior vena cava.[18] If two cannula are required (single-stage cannulation), the first one is typically passed through the superior vena cava and the second through the inferior vena cava.[18] The femoral vein
may also be cannulated in select patients.

If the heart must be stopped for the operation,

right ventricle. The cannula is placed in this incision, passed through the tricuspid valve, and into the coronary sinus.[17][18]
The cardioplegia lines are connected to the CPB machine.

At this point, the patient is ready to go on bypass. Blood from the venous cannula(s) enters the CPB machine by gravity where it is oxygenated and cooled (if necessary) before returning to the body through the arterial cannula. Cardioplegia can now be administered to stop the heart, and a cross-clamp is placed across the aorta between the arterial cannula and cardioplegia cannula to prevent the arterial blood from flowing backwards into the heart. Setting appropriate blood pressure targets to maintain the health and function of the organs including the brain and kidney are important considerations.[21]

Once the patient is ready to come off of bypass support, the cross-clamp and cannulas are removed and protamine sulfate is administered to reverse the anticoagulative effects of heparin.

History

A heart lung machine used in London's Middlesex Hospital in 1958. Science Museum, London (2008)
University of Leipzig.[22]

The Soviet scientist Sergei Brukhonenko developed a heart-lung machine for total body perfusion in 1926 named the Autojektor, which was used in experiments with canines.

Soon after on April 5, 1951, Dr.

University of Minnesota Medical Center
, conducted the first human operation involving Cardiotomy. This was a temporary mechanical takeover of both heart and lung functions.

The first successful mechanical support of left ventricular function was performed on July 3, 1952, by

Dodrill-GMR. The machine was later used to support the right ventricular function.[23]

The first successful open heart procedure on a human utilizing the heart lung machine was performed by John Gibbon and Frank F. Allbritten, Jr.[24] on May 6, 1953, at Thomas Jefferson University Hospital in Philadelphia.

In 1983, Ken Litzie patented a closed emergency heart bypass system which reduced circuit and component complexity.[25] This device improved patient survival after cardiac arrest because it could be rapidly deployed in non-surgical settings.[26]


See also

Membrane oxygenator

References

  1. .
  2. .
  3. .
  4. .
  5. .
  6. , retrieved 2020-01-21
  7. .
  8. .
  9. .
  10. ^
    OCLC 930496902.{{cite book}}: CS1 maint: location missing publisher (link
    )
  11. ^ .
  12. ^ .
  13. ^ Man survives 16 days without a heart United Press International. April 3, 2008.
  14. PMID 18816305
    .
  15. ^ Stutz B (9 January 2009). "Pumphead: Does the heart-lung machine have a dark side?". Scientific American.
  16. ^ Davies H. "Cardiopulmonary bypass machine - CPB". www.ebme.co.uk. Retrieved 2019-11-21.
  17. ^
    OCLC 922073684
    .
  18. ^ .
  19. OCLC 930496902.{{cite book}}: CS1 maint: location missing publisher (link
    )
  20. .
  21. .
  22. .
  23. .
  24. .
  25. ^ US 4540399, Litzie K, Roberts CP, "US Patent for Emergency bypass system", issued 10 September 1985, assigned to C.R. Bard, Inc and Lifestream International, LLC. 
  26. PMID 2297254
    .

Further reading

External links